日本预防心脑血管疾病的综合风险管理 - Suppr

Suppr

超能文献

Comprehensive Risk Management for the Prevention of Cerebro- Cardiovascular Diseases in Japan.

出版信息

J Atheroscler Thromb. 2017 Jul 1;24(7):749-764. doi: 10.5551/jat.CR001. Epub 2017 Jun 23.

DOI:10.5551/jat.CR001

PMID:28652526

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5517548/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29bc/5517548/49209de5f6c3/jat-24-749-g002.jpg

相似文献

Comprehensive Risk Management for the Prevention of Cerebro- Cardiovascular Diseases in Japan.

J Atheroscler Thromb. 2017 Jul 1;24(7):749-764. doi: 10.5551/jat.CR001. Epub 2017 Jun 23.

Comprehensive risk management for the prevention of cerebro- cardiovascular diseases in Japan.

Hypertens Res. 2017 Oct 5;40(10):847-855. doi: 10.1038/hr.2016.155. Epub 2017 Jul 13.

Comprehensive risk management for the prevention of cerebro- cardiovascular diseases in Japan.

Geriatr Gerontol Int. 2017 Aug;17(8):1145-1154. doi: 10.1111/ggi.13122. Epub 2017 Aug 4.

Comprehensive risk management for the prevention of cerebro-cardiovascular diseases in Japan.

Clin Exp Nephrol. 2017 Oct;21(5):743-754. doi: 10.1007/s10157-017-1456-z.

[Comprehensive risk management chart for the prevention of cerebro- and cardiovascular diseases].

Nihon Naika Gakkai Zasshi. 2015 Apr 10;104(4):824-59. doi: 10.2169/naika.104.824.

Striking the right balance.

Health Rep. 1994;6(1):171-3.

Clinical and epidemiological study of eicosapentaenoic acid (EPA) in Japan.

J Nutr Sci Vitaminol (Tokyo). 1992;Spec No:140-3. doi: 10.3177/jnsv.38.special_140.

[Build up broad concept of prevention and prevent the pandemic of cardiovascular and cerebrovascular diseases].

Zhonghua Yu Fang Yi Xue Za Zhi. 2008 Jun;42(6):381-3.

Highlights From the American Heart Association's EPI|LIFESTYLE 2019 Scientific Sessions.

J Am Heart Assoc. 2019 Jun 4;8(11):e012925. doi: 10.1161/JAHA.119.012925. Epub 2019 Jun 1.

Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012.

J Atheroscler Thromb. 2013;20(7):603-15. doi: 10.5551/jat.15867. Epub 2013 Jul 25.

引用本文的文献

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

J Atheroscler Thromb. 2018 Sep 1;25(9):846-984. doi: 10.5551/jat.GL2017. Epub 2018 Aug 22.

Cultural Barriers in the Treatment of Dyslipidemia: A Survey of Japanese Physician Attitudes.

J Atheroscler Thromb. 2019 Feb 1;26(2):154-169. doi: 10.5551/jat.44677. Epub 2018 May 18.

本文引用的文献

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Lancet. 2010 Jun 12;375(9731):2073-81. doi: 10.1016/S0140-6736(10)60674-5. Epub 2010 May 17.

[Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases].

J Atheroscler Thromb. 2007 Apr:5-57.

[Definition and the diagnostic standard for metabolic syndrome--Committee to Evaluate Diagnostic Standards for Metabolic Syndrome].

Nihon Naika Gakkai Zasshi. 2005 Apr 10;94(4):794-809.

Smoking cessation and mortality from cardiovascular disease among Japanese men and women: the JACC Study.

Am J Epidemiol. 2005 Jan 15;161(2):170-9. doi: 10.1093/aje/kwi027.

Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction.

J Am Coll Cardiol. 2001 May;37(6):1677-82. doi: 10.1016/s0735-1097(01)01195-0.

Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen.

Am J Med. 1993 Sep;95(3):309-14. doi: 10.1016/0002-9343(93)90284-v.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验